Clinical Trials Logo

Cancer Pain clinical trials

View clinical trials related to Cancer Pain.

Filter by:

NCT ID: NCT03895762 Completed - Clinical trials for Breakthrough Cancer Pain

Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients

OASIS
Start date: July 4, 2017
Phase:
Study type: Observational

The purpose of this observational study is: To observe the efficacy, safety, and tolerability of Abstral ODT for the alleviation of breakthrough cancer pain in Korean patients with various cancers in real-world clinical settings and supplement and expand the previous cross-sectional survey results.

NCT ID: NCT03736746 Completed - Other Cancer Clinical Trials

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

Start date: November 16, 2018
Phase: N/A
Study type: Interventional

This research study is evaluating the acceptability and feasibility of using a cognitive behavioral intervention called Motivational Interviewing to help persons with pain from cancer set goals for managing that pain.

NCT ID: NCT03727373 Completed - Pain, Acute Clinical Trials

Qualitative Study for Pain Measurement Using Innovative Health Technology

QualiPain
Start date: October 17, 2018
Phase:
Study type: Observational

The present study is a multicenter, explorative, qualitative study. The primary endpoint of this study is to evaluate to which extent the collection of data with regard to pain caused by illness or treatment can be optimized using health technology solutions. For this evaluation semi-structured qualitative interviews with 8-10 patients will be conducted. Secondary variables are the evaluation of the patients' pain experience and the general patients' willingness to collect data with regard to pain by using technological devices themselves or with support of healthcare professionals.

NCT ID: NCT03686605 Completed - Clinical trials for Screening Tool for Depresion in Cancer Pain Patients

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Start date: September 24, 2018
Phase:
Study type: Observational [Patient Registry]

Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening tool for depression in cancer pain patients

NCT ID: NCT03669263 Completed - Clinical trials for Breakthrough Cancer Pain

A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan

Start date: November 25, 2014
Phase: N/A
Study type: Interventional

Primary Objective: To determine the feasible dose range of Painkyl® required for Taiwanese population. Secondary Objectives: To evaluate the efficacy of Painkyl® by calculating squared mean of pain intensity difference at 30 minutes after taking Painkyl® (SPID30, an 11-point scale). To evaluate subjects' satisfaction by conducting global evaluation of medication performance (a 5-point categorical scale). To identify percentage of episodes requiring rescue medication during maintenance treatment period. To evaluate the safety data of Painkyl® for breakthrough pain.

NCT ID: NCT03641222 Completed - Pain Clinical Trials

Group Versus Individual Acupuncture for Cancer Pain

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

Typically, in North America, acupuncture is performed on an individual basis. However, community acupuncture, also known as group acupuncture, is an emerging method of treating patients. Cancer patients, post-treatments were given acupuncture treatments to help alleviate pain, in a two-arm randomized trial.

NCT ID: NCT03638440 Completed - Clinical trials for Opioid Induced Constipation

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.

NACASY
Start date: August 16, 2018
Phase:
Study type: Observational

This is a single-arm, open label, multinational, multicentre, prospective, real world observational study of Naloxegol in adult subjects with Opioid Induced Constipation (OIC) in patients receiving Naloxegol in routine clinical practice. Subjects who are receiving Naloxegol (prescribed by their physician according to the SmPC, which recommends that all currently used maintenance laxative therapy should be halted) during the enrolment period may be eligible for enrolment into the study.

NCT ID: NCT03606811 Completed - Clinical trials for Intractable Pelvic Cancer Pain

Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain

Start date: August 5, 2018
Phase: N/A
Study type: Interventional

fluoroscopic group & includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group & includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.

NCT ID: NCT03597737 Completed - Pain, Acute Clinical Trials

Utility of an APP for the Monitoring of Irruptive Oncological Pain

Start date: August 10, 2018
Phase: N/A
Study type: Interventional

The present investigation aims at exploring the effect of including a pain app called Pain Monitor irruptive oncological pain for chronic pain patients' daily monitoring. Two conditions will be set: 1. usual treatment (waiting list) 2. usual treatment + APP

NCT ID: NCT03546023 Completed - Chronic Cancer Pain Clinical Trials

Brief Pain Inventory to Assess Cancer Pain and Quality of Life

Start date: June 5, 2018
Phase:
Study type: Observational

Cancer-related pain has a major adverse impact on functional status and quality of life. Recently, a Survey conducted in 2015 in 10 Asian countries showed that among cancer patients in Asian population, 86% of patients reported that their pain affected their activities of daily living, 87% their sleep, 92% their concentration and focus, and 67% excessive reliance on others. Only 34% reported a good quality of life. Effective pain management may help the patient to focus on the positive aspects of life, decreasing the focus on pain and also promote better adherence to reasonable treatment plans. Hence the emphasis is on improving the Quality of Life and not mere pain control.